Home › Funds › CLARK ESTATES INC/NY › GEHC

CLARK ESTATES INC/NY position in GEHC

GE HEALTHCARE TECHNOLOGIES I · Health Care

CLARK ESTATES INC/NY reported holding 265,000 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 4.03% of its reported portfolio and ranking #6 among its reported holdings. CLARK ESTATES INC/NY has disclosed GEHC holdings in 8 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)265.00K sh
Reported value held$17.32M
Portfolio Weight4.03%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CLARK ESTATES INC/NY's GEHC position evolved

CLARK ESTATES INC/NY first disclosed a stake in GEHC in Q3 2023 at 325,000 shares (US$22.1M). The position peaked in Q4 2023 at 325,000 shares, worth US$25.1M. Across 8 filings, CLARK ESTATES INC/NY increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 265,000 shares valued at US$17.3M. Notable position changes include a 31% trim in Q1 2024 (shares fell 14% over the following quarter), a 40% trim in Q3 2024 (shares fell 16% over the following quarter), a 74% trim in Q1 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 325.00K $22.11M New
Q4 2023 325.00K $25.13M Hold
Q1 2024 225.00K $20.45M Reduce
Q2 2024 190.12K $14.81M Reduce
Q3 2024 115.00K $10.79M Reduce
Q4 2024 115.00K $8.99M Hold
Q1 2025 30.00K $2.42M Reduce
Q3 2026 265.00K $17.32M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GEHC and 13F data

GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GEHC

All GEHC fund holders →

FAQ

How long has CLARK ESTATES INC/NY held GEHC?

CLARK ESTATES INC/NY has disclosed GEHC holdings in 8 of the last 13 reported quarters, going back to Q3 2023.

What is CLARK ESTATES INC/NY's current position in GEHC?

As of Q3 2026, CLARK ESTATES INC/NY holds 265.00K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $17.32M, representing 4.03% of its reported portfolio and ranking #6.

Has CLARK ESTATES INC/NY been buying or selling GEHC?

In the latest 13F filing (Q3 2026), CLARK ESTATES INC/NY newly opened its position in GEHC. The position peaked in Q4 2023 at 325.00K shares.

Which other funds hold GEHC?

Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.